Sabby Management, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History

Sabby Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.25 - $3.79 $296,246 - $898,218	236,997 New	236,997 $303,000
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.9 $174,358 - $263,098	44,593 New	44,593 $217,000
Q1 2023 May 15, 2023	SELL	$3.79 - $4.87 $22,323 - $28,684	-5,890 Reduced 17.07%	28,610 $119,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $5.99 $7,560 - $26,955	4,500 Added 15.0%	34,500 $146,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $2.66 $4,200 - $79,800	30,000 New	30,000 $48,000
Q2 2021 Aug 16, 2021	SELL	$4.05 - $8.7 $1.69 Million - $3.64 Million	-418,437 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.4 - $9.49 $324,739 - $570,700	60,137 Added 16.78%	418,437 $2.4 Million
Q4 2020 Feb 16, 2021	BUY	$7.92 - $11.16 $2.84 Million - $4 Million	358,300 New	358,300 $3.13 Million

9.96M

133K

43.9K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $23.1M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.